FindTrial
Sign In

Role of Platelet rich plasma in thin endometrium in patients with infertility

Study of role of PRP (platelet rich plasma) in thin endometrium in patients with infertility: an open label randomized controlled study - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061966
Enrollment
38
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Department of Obstetrics and Gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women attending the infertility clinic and scheduled to undergo frozen emnryo transfer (FET). Aged 18-40 years. Endometrial thickness 7 mm Basal FSH 10 IU L At least 2 frozen good-quality blastocyst-stage embryos

Exclusion criteria

Exclusion criteria: Abnormal findings on diagnostic hysteroscopy Hematological disorder Chromosomal or genetic abnormalities Hormonal disorders

Design outcomes

Primary

MeasureTime frame
Role of PRP (Platelet Rich Plasma) as compared to EV (Estradiol Valerate) in management of thin endometrium in patients with infertilityTimepoint: 24 to 48hrs—

Secondary

MeasureTime frame
To study and compare the effect of PRP and EV on endometrial thickness among infertile women undergoing IUI. 2. To study and compare the effect of PRP and EV on successful implantation rates. 3. To study and compare the effect of PRP and EV on successful chemical and clinical pregnancy rates. 4. To study and compare the effect of PRP and EV in terms of adverse events like abortions. Timepoint: 10 days—

Countries

India

Contacts

Public ContactDr Vandana Solanki

King Georges Medical University Lucknow

solanki.vandana@gmail.com9582719772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026